Drug discovery and chemokine receptor antagonists: eppur si muove!
- 30 November 2004
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 3 (7-8) , 550-556
- https://doi.org/10.1016/j.autrev.2004.07.037
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- I-TAC/CXCL11 is a natural antagonist for CCR5Journal of Leukocyte Biology, 2004
- Adhesion mechanisms regulating the migration of monocytesNature Reviews Immunology, 2004
- Unusual Chemokine Receptor Antagonism Involving a Mitogen-Activated Protein Kinase PathwayThe Journal of Immunology, 2004
- Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5Journal of Biological Chemistry, 2004
- Lymphocyte trafficking across high endothelial venules: dogmas and enigmasNature Reviews Immunology, 2004
- Do phosphoinositide 3-kinases direct lymphocyte navigation?Trends in Immunology, 2004
- Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytesBlood, 2003
- CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11European Journal of Immunology, 2003
- The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3Journal of Biological Chemistry, 2001
- ChemokinesImmunity, 2000